Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimasertib in Advanced Hematological Malignancies
NCT00957580Phase 2Terminated
- Sponsor
- EMD Serono
- Start
- Sep 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pimasertib in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), multiple myeloma (MM), myeloproliferative neoplasms (MPN), acute lymphoblastic leukemia (ALL), sponsored by EMD Serono. Started Sep 2009; status: terminated.
02
Drugs
pimasertib
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)multiple myeloma (MM)myeloproliferative neoplasms (MPN)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00957580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957580.